Grants per year
Personal profile
Research Interests
The Perera laboratory focuses on pharmacogenomics (using a patient's genome to predict drug response) in minority populations. Working in this translation research space requires both clinical expertise as well as the use of high-throughput basic science approaches. Our goal is to bring the benefits of precision medicine to all US populations.
Training Experience
| 2006 | Postdoctoral Fellowship, University of Chicago |
Education/Academic qualification
PhD, Ohio State University
… → 2003
Pharmacology, PharmD, University of Tennessee
… → 2001
Research interests
- Adverse Drug Reactions
- Autoimmune Diseases
- Gene Regulation
- Genomic Medicine/Personalized Medicine
- Inflammatory Bowel Disease
- Pharmacogenomics
- Pharmacology
Fingerprint
Dive into the research topics where Minoli Perera is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
-
Northwestern Genomic Risk Assessment and Management Program
Chisholm, R. L., Aufox, S. A., Smith, M. E., Kho, A. N., Walunas, T. L., Rasmussen-Torvik, L. J., Starren, J. B., McNally, E. M., Scherr, C. E. L., Wehbe, F., Luo, Y., Hoell, C., Perera, M., Scholtens, D. M., Roy-Puckelwartz, M. J. & Gordon, A. S.
National Human Genome Research Institute
7/1/20 → 4/30/25
Project: Research project
-
African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation
National Institute on Minority Health and Health Disparities
8/19/16 → 5/31/21
Project: Research project
Research Output
-
Discovery of novel hepatocyte eQTLs in African Americans
Zhong, Y., De, T., Alarcon, C., Sehwan Park, C., Lec, B. & Perera, M. A., Apr 2020, In: PLoS genetics. 16, 4, e1008662.Research output: Contribution to journal › Article › peer-review
Open Access -
Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis
Asiimwe, I. G., Zhang, E. J., Osanlou, R., Krause, A., Dillon, C., Suarez-Kurtz, G., Zhang, H., Perini, J. A., Renta, J. Y., Duconge, J., Cavallari, L. H., Marcatto, L. R., Beasly, M. T., Perera, M. A., Limdi, N. A., Santos, P. C. J. L., Kimmel, S. E., Lubitz, S. A., Scott, S. A., Kawai, V. K. & 2 others, , Jun 1 2020, In: Clinical pharmacology and therapeutics. 107, 6, p. 1420-1433 14 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Impact of CYP2C9-Interacting Drugs on Warfarin Pharmacogenomics
Agrawal, S., Heiss, M. S., Fenter, R. B., Abramova, T. V., Perera, M. A., Pacheco, J. A., Smith, M. E., Rasmussen-Torvik, L. J. & George, A. L., Sep 1 2020, In: Clinical and Translational Science. 13, 5, p. 941-949 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacogenomic genotypes define genetic ancestry in patients and enable population-specific genomic implementation
Hernandez, W., Danahey, K., Pei, X., Yeo, K. T. J., Leung, E., Volchenboum, S. L., Ratain, M. J., Meltzer, D. O., Stranger, B. E., Perera, M. A. & O’Donnell, P. H., Feb 1 2020, In: Pharmacogenomics Journal. 20, 1, p. 126-135 10 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Why African Americans say "no": A study of pharmacogenomic research participation
Nooruddin, M., Scherr, C., Friedman, P., Subrahmanyam, R., Banagan, J., Moreno, D., Sathyanarayanan, M., Nutescu, E., Jeyaram, T., Harris, M., Zhang, H., Rodriguez, A., Shaazuddin, M., Perera, M. & Tuck, M., 2020, In: Ethnicity and Disease. 30, p. 159-166 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations